Recently, Keckesova et al described LACTB as a novel tumor suppressor in breast cancer, showing that LACTB has the ability to change mitochondrial lipid metabolism and, through such reprogramming, to modulate the differentiation state of cancer cells (18). This evidence concerns the gene LACTB and cancer.